Home › Funds › NAN FUNG TRINITY (HK) Ltd › XENE

NAN FUNG TRINITY (HK) Ltd position in XENE

XENON PHARMACEUTICALS INC · Health Care

NAN FUNG TRINITY (HK) Ltd reported holding 247,765 shares of XENE (XENON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$9.2M, representing 0.88% of its reported portfolio and ranking #42 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed XENE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)247.76K sh
Reported value held$9.21M
Portfolio Weight0.88%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NAN FUNG TRINITY (HK) Ltd's XENE position evolved

NAN FUNG TRINITY (HK) Ltd first disclosed a stake in XENE in Q2 2025 at 158,605 shares (US$5.0M). The position peaked in Q2 2026 at 247,765 shares, worth US$15.0M. Across 6 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 247,765 shares valued at US$9.2M. Notable position changes include a 43% increase in Q4 2025 (shares rose 30% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 158.60K $4.96M New
Q3 2025 158.60K $6.37M Hold
Q4 2025 226.97K $10.17M Add
Q1 2026 247.76K $14.41M Add
Q2 2026 247.76K $14.96M Hold
Q3 2026 247.76K $9.21M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XENE and 13F data

XENE (XENON PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in XENE — the largest reported positions include Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XENE

All XENE fund holders →

FAQ

How long has NAN FUNG TRINITY (HK) Ltd held XENE?

NAN FUNG TRINITY (HK) Ltd has disclosed XENE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is NAN FUNG TRINITY (HK) Ltd's current position in XENE?

As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 247.76K shares of XENE (XENON PHARMACEUTICALS INC), valued at $9.21M, representing 0.88% of its reported portfolio and ranking #42.

Has NAN FUNG TRINITY (HK) Ltd been buying or selling XENE?

In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd held unchanged its position in XENE. The position peaked in Q2 2026 at 247.76K shares.

Which other funds hold XENE?

Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.